Join Now

The voice of utah’s life sciences community

BioUtah is the common voice and flag bearer for Utah’s life sciences industry comprised of medical devices, pharmaceutical, diagnostics, and biotechnology. Together we form an ecosystem that fosters collaboration, promotes innovation and delivers technology that saves lives.

Learn More

Medical Device

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

March 13-14, 2025

Salt Lake City | Snowbird

Learn More

2024 Utah Life Sciences Award Recipients

Lifetime Achievement
Dr. Wm. Dean Wallace

Innovation Impact
Blackrock Neurotech

Entrepreneur of the Year
Jay Muse

Executive of the Year
Bradford Brown

Friend of Industry
Vic Hockett

Utah Life Sciences by the Numbers

Kem C. Gardner Report Findings Nov. 2023

Utah is #3 in the nation for life sciences growth.

Life sciences is a $21.6 billion industry in Utah.

Source: Pace, L. and Brandley, A. (2023), Economic Impacts of Utah’s Life Sciences and Health Care Innovation Industry: Utah’s Life Sciences and Health Care Innovation Industry Creates Substantial Economic Impacts Across the State, Kem C. Gardner Policy Institute, University of Utah.

BioUtah News

April 24, 2025
Policy News
Utah Healthcare Innovation Network (UHIN) Announces Inaugural Cohort of Healthcare Startups

Utah Healthcare Innovation Network (UHIN) Announces Inaugural Cohort of Healthcare Startups

April 24, 2025
BioUtah News
Biologic Input Output Systems (BIOS) Appoints Chris Duncan, MD as Chief Medical Officer to Drive Clinical Innovation

Renowned neuroprosthetics expert joins BIOS to lead clinical strategy and advance development of the Universal Neural Interface.

April 24, 2025
BioUtah News
CLARITY SIGNS HIGH-VOLUME COMMERCIAL-SCALE COPPER-64 SUPPLY AGREEMENT WITH NUSANO

CLARITY SIGNS HIGH-VOLUME COMMERCIAL-SCALE COPPER-64 SUPPLY AGREEMENT WITH NUSANO

April 24, 2025
BioUtah News
ARUP Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathology

The biomarker pTau 217 is associated with Alzheimer’s disease pathology and can be detected in plasma, providing a minimally invasive option to support other diagnostic tests.

April 24, 2025
BioUtah News
PhotoPharmics Closes Oversubscribed $6 Million Series B Extension to Advance FDA Breakthrough Parkinson’s Device

Funding supports key milestones as the Pivotal, Phase 3 trial surpasses 200 enrolled participants.

April 17, 2025
BioUtah News
Congresssional Staffer Tours

Congresssional Staffer Tours

April 17, 2025
BioUtah News
Nelson Labs Celebrates 40 Years of Excellence in Science and Service

Nelson Labs Celebrates 40 Years of Excellence in Science and Service

April 10, 2025
BioUtah News
Peer-Reviewed Article Reporting DiscGenics’ Cell Therapy Phase I/II Study Results Receives International Journal of Spine Surgery Best Paper Award

Salt Lake City, UT – April 9, 2025 – DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, today announced that the double-blind, peer-reviewed article, “Allogeneic Disc Progenitor Cells Safely Increase Disc Volume and Improve Pain, Disability, and Quality of Life in Patients With Lumbar Disc Degeneration—Results […]

From Here to There

See how BioUtah, the only trade association dedicated solely to Utah’s Life Sciences industry, can help your business grow.


Networking

Advocacy

Investment

Workforce Development

BioUtah is Powered by

Legacy Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors